| Sin3: insight into its transcription regulatory functions R Kadamb, S Mittal, N Bansal, H Batra, D Saluja European journal of cell biology 92 (8-9), 237-246, 2013 | 187 | 2013 |
| Tumor suppressor protein p53 recruits human Sin3B/HDAC1 complex for down-regulation of its target promoters in response to genotoxic stress N Bansal, R Kadamb, S Mittal, L Vig, R Sharma, BS Dwarakanath, ... PLoS One 6 (10), e26156, 2011 | 48 | 2011 |
| Invasive phenotype in triple negative breast cancer is inhibited by blocking SIN3A–PF1 interaction through KLF9 mediated repression of ITGA6 and ITGB1 R Kadamb, BA Leibovitch, EF Farias, N Dahiya, H Suryawanshi, N Bansal, ... Translational Oncology 16, 101320, 2022 | 19 | 2022 |
| The Sin3A/MAD1 complex, through its PAH2 domain, acts as a second repressor of retinoic acid receptor beta expression in breast cancer cells NR Dahiya, BA Leibovitch, R Kadamb, N Bansal, S Waxman Cells 11 (7), 1179, 2022 | 5 | 2022 |
| IGF1R Inhibition Enhances the Therapeutic Effects of Gq/11 Inhibition in Metastatic Uveal Melanoma Progression D Lapadula, B Lam, M Terai, T Sugase, R Tanaka, E Farias, R Kadamb, ... Molecular cancer therapeutics 22 (1), 63-74, 2023 | 4 | 2023 |
| Stress-mediated Sin3B activation leads to negative regulation of subset of p53 target genes R Kadamb, S Mittal, N Bansal, D Saluja Bioscience Reports 35 (4), e00234, 2015 | 4 | 2015 |
| Abstract A009: NR2F1 inhibits Gaq/11-YAP-TAZ signaling and limits reactivation of uveal melanoma disseminated cancer cells via induction of dormancy R Kadamb, ML Anton, V Chua, T Purwin, MAN Toledano, A Aplin, ... Cancer Research 83 (2_Supplement_2), A009-A009, 2023 | 1 | 2023 |
| Clinical implementation of biomarkers and signaling pathway as novel targeted therapeutics in breast cancer R Kadamb, S Singh Treatment Landscape of Targeted Therapies in Oncology, 27-56, 2023 | 1 | 2023 |
| Cancer stem cells—Challenges for cancer therapies R Arora, A Uboveja, R Kadamb Cancer Epigenetics and Nanomedicine, 93-120, 2024 | | 2024 |
| Lineage commitment pathways epigenetically oppose oncogenic Gαq/11-YAP signaling in dormant disseminated uveal melanoma R Kadamb, ML Anton, TJ Purwin, V Chua, L Seeneevassen, J Teh, ... bioRxiv, 2024.03. 05.583565, 2024 | | 2024 |
| NR2F1 inhibits Gaq/11-YAP-TAZ signaling and limits reactivation of uveal melanoma disseminated cancer cells via induction of dormancy R Kadamb, ML Anton, V Chua, T Purwin, MAN Toledano, A Aplin, ... CANCER RESEARCH 83 (2), 2023 | | 2023 |
| The aged tumor microenvironment influences tolerance to targeted therapy via NR2F1 overexpression in BRAF-mutant melanoma M Tiago, TJ Purwin, ME Fane, Y Chhabra, JLF Teh, R Kadamb, W Cai, ... CANCER RESEARCH 83 (2), 2023 | | 2023 |
| Abstract A005: The aged tumor microenvironment influences tolerance to targeted therapy via NR2F1 overexpression in BRAF-mutant melanoma M Tiago, TJ Purwin, ME Fane, Y Chhabra, JLF Teh, R Kadamb, W Cai, ... Cancer Research 83 (2_Supplement_1), A005-A005, 2023 | | 2023 |
| Targeted dissociation of PF1 from SIN3A chromatin regulator complex inhibits tumor growth and metastasis in triple-negative breast cancer R Kadamb, N Bansal, BA Leibovitch, YJ Kwon, MM Zhou, E Farias, ... Cancer Research 78 (13_Supplement), 31-31, 2018 | | 2018 |
| p53 activation through stress induction mediates differential regulation of target genes. S Mittal, R Kadamb, N Bansal, D Saluja Cancer Research 73 (8_Supplement), 747-747, 2013 | | 2013 |
| Studying the significance of human p53-Sin3B interaction under the condition of DNA damage. R Kadamb, S Mittal, N Bansal, BSR Dwarakanath, D Saluja Cancer Research 73 (8_Supplement), 748-748, 2013 | | 2013 |
